Ya‐Hui Hu

2.7k total citations
107 papers, 1.7k citations indexed

About

Ya‐Hui Hu is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Surgery. According to data from OpenAlex, Ya‐Hui Hu has authored 107 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Pediatrics, Perinatology and Child Health, 25 papers in Molecular Biology and 20 papers in Surgery. Recurrent topics in Ya‐Hui Hu's work include Pharmacological Effects and Toxicity Studies (16 papers), Hormonal Regulation and Hypertension (15 papers) and Adrenal and Paraganglionic Tumors (13 papers). Ya‐Hui Hu is often cited by papers focused on Pharmacological Effects and Toxicity Studies (16 papers), Hormonal Regulation and Hypertension (15 papers) and Adrenal and Paraganglionic Tumors (13 papers). Ya‐Hui Hu collaborates with scholars based in China, Taiwan and United States. Ya‐Hui Hu's co-authors include Hong‐Li Guo, Feng Chen, Yunman Li, Jing Xu, Vin‐Cent Wu, Yen‐Hung Lin, Weirong Fang, Kwan‐Dun Wu, Shih‐Chieh Chueh and Jing Xia and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Ya‐Hui Hu

99 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ya‐Hui Hu China	23	445	416	402	287	214	107	1.7k
Terezila Machado Coimbra Brazil	28	783 1.8×	225 0.5×	380 0.9×	271 0.9×	404 1.9×	105	2.9k
Anil Bhanudas Gaikwad India	29	908 2.0×	376 0.9×	257 0.6×	268 0.9×	94 0.4×	110	2.3k
Jaechan Leem South Korea	26	632 1.4×	231 0.6×	153 0.4×	240 0.8×	117 0.5×	72	1.8k
Olena Glushakova United States	21	746 1.7×	635 1.5×	198 0.5×	410 1.4×	138 0.6×	27	2.5k
I. Serés Hungary	31	458 1.0×	260 0.6×	399 1.0×	323 1.1×	67 0.3×	128	2.8k
Ji Hee Lim South Korea	28	901 2.0×	349 0.8×	294 0.7×	497 1.7×	78 0.4×	46	2.2k
Carlos Martı́nez-Salgado Spain	28	959 2.2×	148 0.4×	209 0.5×	416 1.4×	114 0.5×	95	2.6k
Toshimasa Yoshioka Japan	28	688 1.5×	272 0.7×	178 0.4×	328 1.1×	146 0.7×	61	2.4k
Mi Ra Yu South Korea	24	887 2.0×	206 0.5×	346 0.9×	256 0.9×	70 0.3×	41	2.1k
Dae Ryong South Korea	32	1.1k 2.5×	667 1.6×	355 0.9×	484 1.7×	96 0.4×	93	3.1k

Countries citing papers authored by Ya‐Hui Hu

Since Specialization

Citations

This map shows the geographic impact of Ya‐Hui Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ya‐Hui Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ya‐Hui Hu more than expected).

Fields of papers citing papers by Ya‐Hui Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ya‐Hui Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ya‐Hui Hu. The network helps show where Ya‐Hui Hu may publish in the future.

Co-authorship network of co-authors of Ya‐Hui Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Ya‐Hui Hu. A scholar is included among the top collaborators of Ya‐Hui Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ya‐Hui Hu. Ya‐Hui Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xu, Jing, et al.. (2025). Celastrol Ameliorates Vincristine-induced Neuropathic Pain by Inhibiting Spinal Astrocyte Hyperactivation-mediated Inflammation, Oxidative Stress, and Apoptosis. Current Neuropharmacology. 24(3). 419–432.

Guo, Hong‐Li, Na Dong, Ya‐Hui Hu, et al.. (2025). Serum HDL-C levels in children with epilepsy: a single-center retrospective study. Frontiers in Nutrition. 12. 1523426–1523426. 1 indexed citations

Zhang, Yuanyuan, Hongli Guo, Weijun Wang, et al.. (2024). LC-MS/MS and EMIT measure the whole blood concentration of cyclosporine A: The two methods yield concordant results within the dynamic range of the latter, but the former shows broader application scenarios. Journal of Chromatography B. 1240. 124154–124154. 1 indexed citations

Guo, Hong‐Li, Di Fu, Yue Li, et al.. (2024). Individualized atomoxetine response and tolerability in children with ADHD receiving different dosage regimens: the need for CYP2D6 genotyping and therapeutic drug monitoring to dance together. Translational Psychiatry. 14(1). 151–151. 4 indexed citations

Liu, Yun, Hong‐Li Guo, Keyu Lu, et al.. (2024). A small step toward precision dosing of caffeine in preterm infants: An external evaluation of published population pharmacokinetic models. European Journal of Pharmaceutics and Biopharmaceutics. 204. 114484–114484.

Zhang, Weimin, et al.. (2024). Pericoronary adipose tissue radiomics features as imaging markers for coronary artery disease risk assessment: insights from gene expression analysis. Cardiovascular Diabetology. 23(1). 444–444. 1 indexed citations

Fan, Lin, Hong‐Li Guo, Weijun Wang, et al.. (2024). Population pharmacokinetic study in children with vascular anomalies: body weight as a key variable in predicting the initial dose and dosing frequency of sirolimus. Frontiers in Pharmacology. 15. 1457614–1457614.

Wang, Weijun, Ya‐Hui Hu, Jie Wang, et al.. (2024). Population pharmacokinetics of valproic acid in children with epilepsy: Implications for dose tailoring when switching from oral syrup to sustained‐release tablets. CPT Pharmacometrics & Systems Pharmacology. 13(9). 1554–1569. 1 indexed citations

Wang, Qian, Xin Liu, Jin Su Song, et al.. (2024). Ginsenoside Rb1 targets to HO-1 to improve sepsis by inhibiting ferroptosis. Free Radical Biology and Medicine. 226. 13–28. 9 indexed citations

10.

Zhang, Rui-Xiao, Ya‐Hui Hu, Chenchen Cui, & Cuilian Zhang. (2024). Which factors affect the live birth outcome of the first single euploid frozen-thawed blastocyst transfer in couples with balanced chromosomal translocations?. Frontiers in Endocrinology. 15. 1378635–1378635.

11.

Wang, Jie, Weijun Wang, Jian Huang, et al.. (2024). CYP2C19 genotype and sodium channel blockers in lacosamide-treated children with epilepsy: two major determinants of trough lacosamide concentration or clinical response. Therapeutic Advances in Neurological Disorders. 17. 4233554175–4233554175. 1 indexed citations

12.

Hu, Ya‐Hui, et al.. (2023). Shenhuangdan decoction alleviates sepsis-induced lung injury through inhibition of GSDMD-mediated pyroptosis. Journal of Ethnopharmacology. 318(Pt B). 117047–117047. 9 indexed citations

13.

Ge, Jing, Rui Zhou, Ya‐Hui Hu, et al.. (2023). The activity of cuproptosis pathway calculated by AUCell algorithm was employed to construct cuproptosis landscape in lung adenocarcinoma. Discover Oncology. 14(1). 135–135. 6 indexed citations

14.

Chang, Yu‐Ling, Bo‐Ching Lee, Ching‐Chu Lu, et al.. (2023). Strategies for subtyping primary aldosteronism. Journal of the Formosan Medical Association. 123. S114–S124. 4 indexed citations

15.

Hu, Ya‐Hui, Hong‐Li Guo, Yuanyuan Zhang, et al.. (2022). Therapeutic drug monitoring of perampanel in children diagnosed with epilepsy: Focus on influencing factors on the plasma concentration‐to‐dose ratio. Epilepsia Open. 7(4). 737–746. 13 indexed citations

16.

Yang, Qingyan, Ya‐Hui Hu, Hong‐Li Guo, et al.. (2021). Vincristine-Induced Peripheral Neuropathy in Childhood Acute Lymphoblastic Leukemia: Genetic Variation as a Potential Risk Factor. Frontiers in Pharmacology. 12. 771487–771487. 17 indexed citations

17.

Qiu, Jin‐Chun, Hong‐Li Guo, Ling Li, et al.. (2020). Valproic acid therapy decreases serum 25-hydroxyvitamin D level in female infants and toddlers with epilepsy— a pilot longitudinal study. Journal of Biomedical Research. 35(1). 61–61. 8 indexed citations

18.

Xiong, Ying, Yan Ma, Weirong Fang, et al.. (2019). Protective effects of Clematichinenoside AR against inflammation and cytotoxicity induced by human tumor necrosis factor-α. International Immunopharmacology. 75. 105563–105563. 14 indexed citations

19.

Qiu, Yue, Xue Pan, & Ya‐Hui Hu. (2019). Polydatin ameliorates pulmonary fibrosis by suppressing inflammation and the epithelial mesenchymal transition via inhibiting the TGF-β/Smad signaling pathway. RSC Advances. 9(14). 8104–8112. 13 indexed citations

20.

Wu, Vin‐Cent, Shuo‐Meng Wang, Chia‐Hui Chang, et al.. (2016). Long term outcome of Aldosteronism after target treatments. Scientific Reports. 6(1). 32103–32103. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact